ArticleAntiviral research2014
Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.
Monica M Sauter et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it